RemiFemin
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline's mass market launch of black cohosh supplement includes campaign offering women "freedom kit" with coupons, menopause symptom-tracking journal and quarterly health magazine. GSK also is partnering with Cedars-Sinai Integrative Medicine Medical Group and SusanLoveMd.com in an educational program that kicks off this month with a three-part Web chat series on women's health, menopause and herbals. GSK obtained North American marketing rights from German herbals firm Schaper & Brummer; RemiFemin has been sold for the past four years in U.S. health food stores by Enzymatic Therapy. Product is available in 60- and 120-counts, carrying SRPs of $20 and $35.29. TV spots, print ads in women's magazines broke in February; agency is Creative Advertising Solutions (New York)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning